As of 2025-08-04, the Relative Valuation of Bristol-Myers Squibb Co (BMY) is 66.17 USD. This relative valuation is based on P/E multiples. With the latest stock price at 44.23 USD, the upside of Bristol-Myers Squibb Co based on Relative Valuation is 49.6%.
The range of the Relative Valuation is 53.26 - 77.65 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.4x - 29.2x | 27.4x |
| Forward P/E multiples | 20.0x - 24.3x | 22.4x |
| Fair Price | 53.26 - 77.65 | 66.17 |
| Upside | 20.4% - 75.6% | 49.6% |
| Date | P/E |
| 2025-08-01 | 16.61 |
| 2025-07-31 | 16.26 |
| 2025-07-30 | 17.27 |
| 2025-07-29 | 17.60 |
| 2025-07-28 | 17.84 |
| 2025-07-25 | 18.19 |
| 2025-07-24 | 18.38 |
| 2025-07-23 | 18.39 |
| 2025-07-22 | 18.03 |
| 2025-07-21 | 17.53 |
| 2025-07-18 | 17.79 |
| 2025-07-17 | 18.05 |
| 2025-07-16 | 17.71 |
| 2025-07-15 | 17.44 |
| 2025-07-14 | 17.78 |
| 2025-07-11 | 17.60 |
| 2025-07-10 | 18.22 |
| 2025-07-09 | 17.90 |
| 2025-07-08 | 17.67 |
| 2025-07-07 | 17.46 |
| 2025-07-03 | 17.62 |
| 2025-07-02 | 17.89 |
| 2025-07-01 | 17.84 |
| 2025-06-30 | 17.38 |
| 2025-06-27 | 17.41 |
| 2025-06-26 | 17.52 |
| 2025-06-25 | 17.53 |
| 2025-06-24 | 17.66 |
| 2025-06-23 | 17.62 |
| 2025-06-20 | 17.60 |
| 2025-06-18 | 17.59 |
| 2025-06-17 | 17.74 |
| 2025-06-16 | 18.27 |
| 2025-06-13 | 18.68 |
| 2025-06-12 | 19.04 |
| 2025-06-11 | 18.84 |
| 2025-06-10 | 18.77 |
| 2025-06-09 | 18.40 |
| 2025-06-06 | 18.18 |
| 2025-06-05 | 17.97 |
| 2025-06-04 | 18.01 |
| 2025-06-03 | 18.06 |
| 2025-06-02 | 18.32 |
| 2025-05-30 | 18.13 |
| 2025-05-29 | 17.97 |
| 2025-05-28 | 17.64 |
| 2025-05-27 | 17.61 |
| 2025-05-23 | 17.59 |
| 2025-05-22 | 17.66 |
| 2025-05-21 | 17.65 |